Barry R. Davis

TL;DR: Thiazide diuretics are safe to use, even in hypertensive individuals at risk for incident glucose disorders, and the use of angiotensin-converting enzyme inhibitors for protection against glucose disorders and subsequent cardiovascular disease remains to be determined.

TL;DR: In this study, which titrated medications to a goal, participants assigned to chlorthalidone were less likely to develop treatment-resistant hypertension, however, prognoses in those with treatment- resistant hypertension were similar across treatment groups.

TL;DR: Clinician setting was predictive of both forms of adherence; adherence was worst at private clinics; clinics that enrolled more study participants had superior adherence; and participant demographics were associated with adherence despite strenuous efforts to optimize adherence.

TL;DR: The Beta-Blocker Heart Attack Trial data show that as the number of hours of ambulatory monitoring increase, the percentages of patients identified at risk or not at risk (the positive and negative predictive values) do not change much, and Twenty-four hours of monitoring does not appear to be the optimal time duration for deciding whether to treat arrhythmias in patients after infarction.

TL;DR: It is concluded that risk reductions associated with C treatment in secondary end points of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial cannot be attributed to differential improvements in electrocardiography LVH.